THE EFFECT OF HISTAMINE H1 RECEPTOR ANTAGONISTS ON THE MORPHINE-INDUCED ANTINOCICEPTION IN THE ACUTE TRIGEMINAL MODEL OF NOCICEPTION IN RATS
DOI:
https://doi.org/10.22159/ajpcr.2017.v10i1.14092Abstract
Objective: In this study, the effect of different classes of histamine H
receptor antagonists (chlorpheniramine, cetirizine, and fexofenadine), µ
opioid receptor agonist (morphine), and opioid receptor antagonist (naloxone) in separate and combined treatments were investigated on the acute
trigeminal model of pain in rats. 1
Methods: Eye wiping test used for induction of acute trigeminal pain by putting a drop of NaCl, 5 M solution (40 µl) on the corneal surface of the eye,
and the number of eye wipes counted during the first 30 seconds.
Results: Intraperitoneal injection of both chlorpheniramine and cetirizine at doses of 10 and 20 mg/kg significantly inhibited the acute trigeminal pain.
However, fexofenadine did not change corneal pain response. Morphine at doses of 1.25, 2.5, and 5 mg/kg reduced eye wipe responses. Administration
of both chlorpheniramine and cetirizine but not fexofenadine before morphine-enhanced morphine analgesic activity, also pretreatment of animals
with naloxone inhibited morphine, chlorpheniramine, and cetirizine-induced analgesia in the acute corneal pain.
Conclusion: Our results showed that chlorpheniramine as a histamine H
antagonist that efficiently Penetrates blood-brain barrier (BBB) and cetirizine with less penetration of BBB but not fexofenadine (an H11
receptor antagonist with a negligible brain-accessibility) could induce analgesia
in the acute corneal pain via opioidergic mechanism. Coadministration of morphine with chlorpheniramine or cetirizine could enhance its analgesic
activity in the acute trigeminal model of pain in rats.
Keywords: Trigeminal pain, Morphine, Histamine H1 receptor antagonists, Naloxone, Rats.
1
ÂObjective:Inthisstudy,theeffectofdifferentclassesofhistamineH
receptorantagonists(chlorpheniramine,cetirizine,andfexofenadine),µ
opioid receptoragonist (morphine), and opioid receptorantagonist (naloxone)in separate and combinedtreatments were investigatedon the acute trigeminal model of pain in rats.
Â
Methods:Eyewiping testusedforinductionofacutetrigeminalpainbyputtingadropofNaCl,5Msolution(40µl)onthecornealsurfaceoftheeye, and the number of eye wipes counted during the first 30 seconds.
Â
Results:Intraperitonealinjectionofbothchlorpheniramineandcetirizineatdosesof10and20mg/kgsignificantlyinhibitedtheacutetrigeminalpain. However,fexofenadinedidnotchangecornealpainresponse.Morphineatdosesof1.25,2.5,and5mg/kgreducedeyewiperesponses.Administration of both chlorpheniramine and cetirizine but not fexofenadine before morphine-enhanced morphine analgesic activity, also pretreatment of animals with naloxone inhibited morphine, chlorpheniramine, and cetirizine-induced analgesia in the acute corneal pain.
Â
1
ÂConclusion:OurresultsshowedthatchlorpheniramineasahistamineH
Â
antagonistthatefficientlyPenetratesblood-brainbarrier(BBB)and
1
ÂcetirizinewithlesspenetrationofBBBbutnotfexofenadine(anH Â receptorantagonistwithanegligiblebrain-accessibility)couldinduceanalgesia in the acute corneal pain via opioidergic mechanism. Coadministration of morphine with chlorpheniramine or cetirizine could enhance its analgesic activity in the acute trigeminal model of pain in rats.
Â
1
ÂKeywords: Trigeminal pain, Morphine, Histamine H Â receptor antagonists, Naloxone, Rats.
Downloads
References
Olsen UB, Eltorp CT, Ingvardsen BK, Jørgensen TK, Lundbaek JA, Thomsen C, et al. ReN 1869, a novel tricyclic antihistamine, is active against neurogenic pain and inflammation. Eur2002;435(1):43-57.JPharmacol
Mobarakeh JI, Sakurada S, Katsuyama S, Kutsuwa M, Kuramasu A, Lin ZY, et al. Role of histamine H(1) receptor in pain perception: A study of the receptor gene knockout mice. Eur J Pharmacol 2000;391(1-2):81-9.
Raffa RB. Antihistamines as analgesics. J Clin Pharm Ther in the modification of Haffner’s tail-clamp procedure when given alone to mice and also caused potentiation when combined with morphine [30]. On the other hand, it has been reported that mepyramine (histamine H receptor antagonist) do not affect the morphine-induced analgesia in p-benzoquinone- induced visceral nociception [31].Another explanation for the potentiation of morphine analgesic 2001;26(2):81-5.
Tamaddonfard E, Khalilzadeh E, Hamzeh-Gooshchi N, Seiednejhad-Yamchi S. Central effect of histamine in a rat model of acute trigeminal pain. Pharmacol Rep 2008;60(2):219-24.
Malmberg-Aiello P, Lamberti C, Ipponi A, Bartolini A, Schunack W. Evidence for hypernociception induction following histamine H1 receptor activation in rodents. Life Sci 1998;63(1):463-76.
Khalilzadeh E, Tamaddonfard E, Farshid AA, Erfanparast A. Microinjection of histamine into the dentate gyrus produces antinociception in the formalin test in rats. Pharmacol Biochem Behav 2010;97(2):325-32.
Abdelaziz MM, Devalia JL, Khair OA, Bayram H, Prior AJ, Davies RJ. Effect of fexofenadine on eosinophil-induced changes in epithelial permeability and cytokine release from nasal epithelial cells of patients with seasonal allergic rhinitis. J Allergy Clin Immunol
;101(3):410-20.
Amon U, Amon S, Gibbs BF. In vitro studies with fexofenadine, a new nonsedating histamine H1 receptor antagonist, on isolated human basophils. Inflamm Res 2000;49 Suppl 1:S13-4.
Anoush M, Mohammad Khani MR. Evaluating the anti-nociceptive and anti-inflammatory effects of ketotifen and fexofenadine in rats. Adv Pharm Bull 2015;5(2):217-22.
Priya M, Narayanan VS, Mohapatra S, Rani RJ. Screening of cetirizine for analgesic activity in mice. Int J Basic Clin Pharmacol
;2(2):187-92.
Basbaum AI, Clanton CH, Fields HL. Opiate and stimulus-produced analgesia: Functional anatomy of a medullospinal pathway. Neurobiology 1976;73(12):4685-8.
Hupert C, Yacoub M, Turgeon LR. Effect of hydroxyzine on morphine analgesia for the treatment of postoperative pain. Anesth Analg 1980;59(9):690-6.
Zanboori A, Tamaddonfard E, Mojtahedein A. Effects of activity by histamine H receptor antagonists may be related to its
chlorpheniramine and ranitidine on the visceral nociception pharmacokinetic modifications occurs in the transfer through the induced by acetic acid in rats: Role of opioid system. Pak J Biol Sci 2008;11(20):2428-32.
Meng ID, Hu JW, Benetti AP, Bereiter DA. Encoding of corneal input in two distinct regions of the spinal trigeminal nucleus in the rat: Cutaneous receptive field properties, responses to thermal and chemical stimulation, modulation by diffuse noxious inhibitory controls, and projections to the parabrachial area. J Neurophysiol 1997;77(1):43-56.
Rosenthal P, Baran I, Jacobs DS. Corneal pain without stain: Is it real? Ocul Surf 2009;7(1):28-40.
Belmonte C, Acosta MC, Gallar J. Neural basis of sensation in intact and injured corneas. Exp Eye Res 2004;78(3):513-25.
Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983;16(2):109-10.
Farazifard R, Safarpour F, Sheibani V, Javan M. Eye-wiping test: A sensitive animal model for acute trigeminal pain studies. Brain Res Brain Res Protoc 2005;16(1-3):44-9.
Khalilzadeh E, Hazrati R, Sayah GV, Hasannejad H. Opioidergic and cholinergic but not nitric oxide pathways are involved in
antinociceptive activity of Vitex agnus-castus essential oil in the acute trigeminal model of pain in rat.Asian J Pharm ClinRes2015;8(1):283-6.
Carstens E, Kuenzler N, Handwerker HO. Activation of neurons in rat trigeminal subnucleus caudalis by different irritant chemicals applied to oral or ocular mucosa. J Neurophysiol 1998;80(2):465-92.
Hirata H, Meng ID. Cold-sensitive corneal afferents respond to a variety of ocular stimuli central to tear production: Implications for dry eye disease. Invest Ophthalmol Vis Sci 2010;51(8):3969-76.
Pan Z, Wang Z, Yang H, Zhang F, Reinach PS. TRPV1 activation is required for hypertonicity-stimulated inflammatory cytokine release in human corneal epithelial cells. Invest Ophthalmol Vis Sci 2011;52(1):485-93.
Mason J, Reynolds R, Rao N. The systemic safety of fexofenadine HCl. Clin Exp Allergy 1999;29 Suppl 3:163-70.
Dogan AS, Catafau AM, Zhou Y, Yanai K, Ravert H, Brasic J, et al. In Vivo Histamine Receptor Occupancy of Two Antihistamine Drugs: A 11C-doxepin PET Study (Poster). Presented at Annual Meeting of the American College of Allergy, Asthma and Immunology, November
, Seattle, Washington. p. 58.
Tashiro M, Mochizuki H, Iwabuchi K, Sakurada Y, Itoh M, Watanabe T, et al. Roles of histamine in regulation of arousal and cognition: Functional neuroimaging of histamine H1 receptors in human brain. Life Sci 2002;72(4-5):409-14.
Slater JW, Zechnich AD, Haxby DG. Second-generation antihistamines: A comparative review. Drugs 1999;57(1):31-47.
Girard P, Pansart Y, Coppé MC, Verniers D, Gillardin JM. Role of the histamine system in nefopam-induced antinociception in mice. Eur J Pharmacol 2004;503(1-3):63-9.
Farzin D, Nosrati F. Modification of formalin-induced nociception by different histamine receptor agonists and antagonists. Eur Neuropsychopharmacol 2007;17(2):122-8.
Galeotti N, Ghelardini C, Bartolini A. Antihistamine antinociception is mediated by Gi-protein activation. Neuroscience 2002;109(4):811-8.
Sun CL, Hui FW, Hanig JP. Effect of H1 blockers alone and in combination with morphine to produce antinociception in mice. Neuropharmacology 1985;24(1):1-4.
Abacioglu N, Bediz A, Cakici I, Tunçtan B, Kanzik I. Antinociceptive effects of H1 - And H2-antihistaminics in mice. Gen
Pharmacol 1993;24(5):1173-6.
Tsuji A, Sakata A, Tamai I. Tissue distribution of the multidrug- resistance gene product P-glycoprotein and its physiological function. Nihon Rinsho 1997;55(5):1059-63.
Ambudkar SV, Dey S, Hrycyna CA, Ramachandra M, Pastan I, Gottesman MM. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol 1999;39:361-98.
Hamabe W, Maeda T, Kiguchi N, Yamamoto C, Tokuyama S, Kishioka S. Negative relationship between morphine analgesia and P-glycoprotein expression levels in the brain. J Pharmacol Sci 2007;105(4):353-60.
Mesgari Abbasi M, Valizadeh H, Hamishekar H, Mohammadnejad L, Zakeri-Milani P. The effects of cetirizine on P-glycoprotein expression and function in vitro and in situ. Adv Pharm Bull 2016;6(1):111-8.
Ghelardini C, Galeotti N, Bartolini A. No development of tolerance to analgesia by repeated administration of H1 antagonists. Life Sci
;63(22):PL 317-22.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
